Guangdong Zhongsheng Pharmaceutical Co Ltd - Asset Resilience Ratio
Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has an Asset Resilience Ratio of 6.62% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Guangdong Zhongsheng Pharmaceutical Co L (002317) strategic investment index to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2024)
This chart shows how Guangdong Zhongsheng Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Guangdong Zhongsheng Pharmaceutical Co L to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Guangdong Zhongsheng Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002317 market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥342.12 Million | 6.62% |
| Total Liquid Assets | CN¥342.12 Million | 6.62% |
Asset Resilience Insights
- Limited Liquidity: Guangdong Zhongsheng Pharmaceutical Co Ltd maintains only 6.62% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Guangdong Zhongsheng Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Guangdong Zhongsheng Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Huadong Medicine Co Ltd
SHE:000963 |
Drug Manufacturers - Specialty & Generic | 0.05% |
|
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026 |
Drug Manufacturers - Specialty & Generic | -0.89% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Fujian Cosunter Pharmaceutical Co Ltd
SHE:300436 |
Drug Manufacturers - Specialty & Generic | -2.56% |
|
Celltrion Pharm Inc
KQ:068760 |
Drug Manufacturers - Specialty & Generic | 12.49% |
|
Hunan Warrant Pharmaceutical Co. Ltd. A
SHG:688799 |
Drug Manufacturers - Specialty & Generic | 0.40% |
|
Harbin Gloria Pharmaceuticals
SHE:002437 |
Drug Manufacturers - Specialty & Generic | 9.04% |
Annual Asset Resilience Ratio for Guangdong Zhongsheng Pharmaceutical Co Ltd (2014–2024)
The table below shows the annual Asset Resilience Ratio data for Guangdong Zhongsheng Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 5.51% | CN¥305.99 Million ≈ $44.78 Million |
CN¥5.55 Billion ≈ $812.65 Million |
-5.07pp |
| 2023-12-31 | 10.58% | CN¥683.06 Million ≈ $99.95 Million |
CN¥6.46 Billion ≈ $945.08 Million |
+4.68pp |
| 2022-12-31 | 5.90% | CN¥340.68 Million ≈ $49.85 Million |
CN¥5.78 Billion ≈ $845.11 Million |
+1.00pp |
| 2021-12-31 | 4.89% | CN¥239.92 Million ≈ $35.11 Million |
CN¥4.90 Billion ≈ $717.31 Million |
-1.53pp |
| 2020-12-31 | 6.42% | CN¥306.65 Million ≈ $44.87 Million |
CN¥4.78 Billion ≈ $698.89 Million |
+6.04pp |
| 2018-12-31 | 0.38% | CN¥20.00 Million ≈ $2.93 Million |
CN¥5.24 Billion ≈ $767.41 Million |
-5.78pp |
| 2017-12-31 | 6.16% | CN¥299.00 Million ≈ $43.75 Million |
CN¥4.86 Billion ≈ $710.60 Million |
-- |
| 2016-12-31 | 0.00% | CN¥0.00 ≈ $0.00 |
CN¥4.23 Billion ≈ $618.31 Million |
-- |
| 2015-12-31 | 5.55% | CN¥185.00 Million ≈ $27.07 Million |
CN¥3.33 Billion ≈ $487.87 Million |
-15.70pp |
| 2014-12-31 | 21.25% | CN¥490.00 Million ≈ $71.70 Million |
CN¥2.31 Billion ≈ $337.49 Million |
-- |
About Guangdong Zhongsheng Pharmaceutical Co Ltd
Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China. The company offers traditional Chinese medicine and chemical medicine. It also focuses on the fields of cardiovascular, respiratory, ophthalmology, and digestive. Guangdong Zhongsheng Pharmaceutical Co., Ltd. was founded in 1979 and is based in Dongguan, China.